IN8bio Aktie - INAB

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,258

Gebot

0,258

Fragen

0,2583

Volumen

27.072

0,00 Tagesbereich 0,00

0,217 52-Wochen-Bereich 1,74

Marktkapitalisierung

18,701M

Handelsende

0,2589

Handelsbeginn

Letzte Trade

1499

0.258

(formt)

Letzter Handelszeitpunkt

10:59:50

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

5.840.816

Ausgegebene Aktien

72.483.253

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,63

Gewinn pro Aktie (EPS)

-0,41

Erlöse

Nettogewinn

-30,01M

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.in8bio.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was US$0,26. Over the last year, IN8bio shares have traded in a share price range of US$ 0,217 to US$ 1,74.

IN8bio currently has 72.483.253 shares in issue. The market capitalisation of IN8bio is US$18,77 million. IN8bio has a price to earnings ratio (PE ratio) of -0.63.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.002899	1.13641263656	0.255101	0.2895	0.2316	2050463	0.26209899	CS
4	-0.0017	-0.654601463227	0.2597	0.4177	0.2316	15363752	0.30269518	CS
12	-0.052	-16.7741935484	0.31	0.4177	0.2303	5840816	0.30181079	CS
26	-0.1722	-40.0278940028	0.4302	0.5566	0.217	3222631	0.31695601	CS
52	-0.942	-78.5	1.2	1.74	0.217	1765292	0.3955374	CS
156	-3.952	-93.8717339667	4.21	4.9799	0.217	1104313	1.3923031	CS
260	-9.742	-97.42	10	10.319	0.217	926380	1.43704249	CS

INAB - Frequently Asked Questions (FAQ)

What is the current IN8bio share price?

The current share price of IN8bio is US$ 0,258

How many IN8bio shares are in issue?

IN8bio has 72.483.253 shares in issue

What is the market cap of IN8bio?

The market capitalisation of IN8bio is USD 18,77M

What is the 1 year trading range for IN8bio share price?

IN8bio has traded in the range of US$ 0,217 to US$ 1,74 during the past year

What is the PE ratio of IN8bio?

The price to earnings ratio of IN8bio is -0,63

What is the reporting currency for IN8bio?

IN8bio reports financial results in USD

What is the latest annual profit for IN8bio?

The latest annual profit of IN8bio is USD -30,01M

What is the registered address of IN8bio?

The registered address for IN8bio is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the IN8bio website address?

The website address for IN8bio is www.in8bio.com

Which industry sector does IN8bio operate in?

IN8bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GTIGraphjet Technology	US$ 0,2411 (74,71%)	775,25k
ARBBARB IOT Group Ltd	US$ 0,8838 (69,96%)	5,84M
GITSGlobal Interactive Technologies Inc	US$ 3,61 (60,12%)	71
AGHAureus Greenway Holdings Inc	US$ 1,03 (33,77%)	4,82M
NVNINVNI Group Ltd	US$ 0,3379 (28,72%)	22,94M
SYRESpyre Therapeutics Inc	US$ 13,13 (-27,94%)	1
RETOReTo Eco Solutions Inc	US$ 0,659 (-25,54%)	56,29k
OMCLOmnicell Inc	US$ 28,00 (-25,11%)	392
OMEROmeros Corporation	US$ 6,01 (-24,69%)	8
ARHSArhaus Inc	US$ 7,01 (-24,30%)	5
NVNINVNI Group Ltd	US$ 0,3379 (28,72%)	22,94M
ARBBARB IOT Group Ltd	US$ 0,8838 (69,96%)	5,84M
BTOGBit Origin Ltd	US$ 0,4404 (23,02%)	5,61M
AGHAureus Greenway Holdings Inc	US$ 1,03 (33,77%)	4,82M
SHViShares Short Treasury Bond ETF	US$ 110,135 (0,01%)	4,13M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IN8bio Inc (INAB) Börsenkurse

IN8bio Inc (INAB)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über IN8bio Inc

INAB Neueste Nachrichten

Form 8-K - Current report

IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases

IN8bio to Present at the TD Cowen 45th Annual Health Care Conference

IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML

Form 8-K - Current report

IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases

IN8bio to Present at the TD Cowen 45th Annual Health Care Conference

IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML

Form 8-K - Current report

IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients

INAB - Frequently Asked Questions (FAQ)

Beweger

INAB Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen